The effect of intravitreal injections on dry eye, and proposed management strategies
Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institu...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/23e486a9f8e542aba69d8c748c58c022 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:23e486a9f8e542aba69d8c748c58c022 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:23e486a9f8e542aba69d8c748c58c0222021-12-02T07:59:13ZThe effect of intravitreal injections on dry eye, and proposed management strategies1177-5483https://doaj.org/article/23e486a9f8e542aba69d8c748c58c0222017-08-01T00:00:00Zhttps://www.dovepress.com/the-effect-of-intravitreal-injections-on-dry-eye-and-proposed-manageme-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institute, Baltimore, MD, USA; 5Singapore National Eye Centre, 6Duke NUS Medical School, 7Yong Loo Lin School of Medicine, National University of Singapore, Singapore Abstract: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents has become a commonly used treatment method for a number of ophthalmic conditions, including age-related macular degeneration. Although anti-VEGF therapy has shown promising results for many patients, there are several aspects of its application that have not been thoroughly investigated. One of these is the development and/or escalation of concurrent dry eye syndrome. Many patients undergoing treatment are already predisposed to dry eye disease due to their age and overall ocular health. As dry eye can have a substantial impact on quality of life, it has become increasingly apparent that the clinical signs and symptoms should be closely monitored and aggressively managed. This will allow for the optimization of patient comfort and visual potential. Here, we discuss the reasons why dry eye may develop during the course of repeated ocular anti-VEGF therapy, highlighting the key concerns about current practices and proposing possible solutions to improve the outcome for the patients. Keywords: age-related macular degeneration, povidone–iodine, toxicity, ocular health, chronic ophthalmic treatmentLaude ALim JWKSrinagesh VTong LDove Medical PressarticleAge-related macular degeneration (AMD)povidone-iodinetoxicityocular healthchronic ophthalmic treatmentOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1491-1497 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Age-related macular degeneration (AMD) povidone-iodine toxicity ocular health chronic ophthalmic treatment Ophthalmology RE1-994 |
spellingShingle |
Age-related macular degeneration (AMD) povidone-iodine toxicity ocular health chronic ophthalmic treatment Ophthalmology RE1-994 Laude A Lim JWK Srinagesh V Tong L The effect of intravitreal injections on dry eye, and proposed management strategies |
description |
Augustinus Laude,1–3 Jimmy WK Lim,1,2 Vishwanath Srinagesh,4 Louis Tong2,5–7 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 2Singapore Eye Research Institute, 3Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 4Krieger Eye Institute, Baltimore, MD, USA; 5Singapore National Eye Centre, 6Duke NUS Medical School, 7Yong Loo Lin School of Medicine, National University of Singapore, Singapore Abstract: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents has become a commonly used treatment method for a number of ophthalmic conditions, including age-related macular degeneration. Although anti-VEGF therapy has shown promising results for many patients, there are several aspects of its application that have not been thoroughly investigated. One of these is the development and/or escalation of concurrent dry eye syndrome. Many patients undergoing treatment are already predisposed to dry eye disease due to their age and overall ocular health. As dry eye can have a substantial impact on quality of life, it has become increasingly apparent that the clinical signs and symptoms should be closely monitored and aggressively managed. This will allow for the optimization of patient comfort and visual potential. Here, we discuss the reasons why dry eye may develop during the course of repeated ocular anti-VEGF therapy, highlighting the key concerns about current practices and proposing possible solutions to improve the outcome for the patients. Keywords: age-related macular degeneration, povidone–iodine, toxicity, ocular health, chronic ophthalmic treatment |
format |
article |
author |
Laude A Lim JWK Srinagesh V Tong L |
author_facet |
Laude A Lim JWK Srinagesh V Tong L |
author_sort |
Laude A |
title |
The effect of intravitreal injections on dry eye, and proposed management strategies |
title_short |
The effect of intravitreal injections on dry eye, and proposed management strategies |
title_full |
The effect of intravitreal injections on dry eye, and proposed management strategies |
title_fullStr |
The effect of intravitreal injections on dry eye, and proposed management strategies |
title_full_unstemmed |
The effect of intravitreal injections on dry eye, and proposed management strategies |
title_sort |
effect of intravitreal injections on dry eye, and proposed management strategies |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/23e486a9f8e542aba69d8c748c58c022 |
work_keys_str_mv |
AT laudea theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT limjwk theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT srinageshv theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT tongl theeffectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT laudea effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT limjwk effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT srinageshv effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies AT tongl effectofintravitrealinjectionsondryeyeandproposedmanagementstrategies |
_version_ |
1718398710215344128 |